Previous 10 | Next 10 |
NEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointments of Hamid Erfanian and Bradley Radoff to the Company’s Board of Directo...
Enzo Biochem, Inc. (ENZ) Q1 2022 Results Conference Call December 15, 2021 04:30 PM ET Company Participants David Holmes - LifeSci Advisors IR Hamid Erfanian - CEO David Bench - CFO Conference Call Participants Paul Nouri - Noble Equity Fund Presentation Operator Greetings. Welcome to the Enz...
BLBD, ENZ, HEI, IRNT, LEN, NDSN, TCOM For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Wednesday's close
Conference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET NEW YORK, NY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report first quarter 2022 financial results on Wedne...
NEW YORK, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that on November 8, 2021, it granted equity awards to Hamid Erfanian. Consistent with the discl...
Expresses Disappointment with Independent Directors’ Hollow and Tone-Deaf Response to a Top 5 Shareholder’s Articulated Concerns and Offer to Pursue a Cooperation Agreement Questions Whether Recently-Appointed Directors Dr. Mary Tagliaferri and Dr. Ian B. W...
GoTestMeNow™ enables individuals to instantly and privately access physician-authorized testing for a broad range of STIs including chlamydia, gonorrhea, syphilis, HIV-1/2, hepatitis and herpes Expanded menu addresses increased patient demand for direct access to othe...
Asserts the Company’s Chief Executive Officer Succession Plan Further Entrenches Dr. Elazar Rabbani, who Will Continue Serving as Chairman and Chief Scientific Officer, Despite Unprecedented Shareholder Opposition and Unrest Calls on the Board to Take Swift Action...
Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer NEW YORK, NY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics...
Enzo Biochem, Inc. (ENZ) Q4 2021 Results Earnings Conference Call October 12, 2021, 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors, LLC Barry Weiner - Co-Founder and President David Bench - Chief Financial Officer Conference Call Participants Paul Nouri - Noble Equity Fund Pres...
News, Short Squeeze, Breakout and More Instantly...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's...
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fis...